| Mobility Prosthetic And Orthotic | |
| 1921 Motor Ave, Ste B, Kingman, Arizona 86401 | |
| (928) 377-4180 |
| Name | Mobility Prosthetic And Orthotic |
|---|---|
| Organization Name | Mobility Prosthetic And Orthotic Services Llc |
| Location | 1921 Motor Ave, Ste B, Kingman, Arizona 86401 |
| Type | Prosthetic/Orthotic Supplier |
| Phone | (928) 377-4180 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
In a study to be presented on Feb. 5 in an oral pleanary session at 8 a.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting™, in San Diego, researchers will report that induced or augmented labor are not associated with increased odds of Autism spectrum disorder.
An RNA-binding protein that is overproduced in ovarian cancer may present a new target for diagnosis or treatment of ovarian and other cancers, according to researchers at the University of Illinois at Chicago.
The costs associated with neurological diseases amount to 1000 billion euros per year in Europe alone.
Barr Pharmaceuticals, Inc. today announced that its subsidiary, Barr Laboratories, Inc., received final approval from the U.S. Food & Drug Administration (FDA) to manufacture and market a generic version of Ortho McNeil Janssen's Razadyne (galantamine hydrobromide), 4 mg, 8 mg and 12 mg tablets. Barr intends to launch its generic Razadyne tablets product immediately.
Human Genome Sciences, Inc. and Aegera Therapeutics, Inc. today announced that HGS has initiated dosing in a Phase 1 clinical trial to evaluate the safety and tolerability of its lead IAP inhibitor, HGS1029, as monotherapy in patients with advanced lymphoid tumors.
› Verified 6 days ago
| NPI Number | 1285258996 |
| Organization Name | MOBILITY PROSTHETIC AND ORTHOTIC SERVICES LLC |
| Type | Prosthetic/Orthotic Supplier |
| Address | 1921 Motor Ave Ste B, Kingman, AZ 86401 |
| Phone Number | 928-377-4125 |
News Archive
In a study to be presented on Feb. 5 in an oral pleanary session at 8 a.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting™, in San Diego, researchers will report that induced or augmented labor are not associated with increased odds of Autism spectrum disorder.
An RNA-binding protein that is overproduced in ovarian cancer may present a new target for diagnosis or treatment of ovarian and other cancers, according to researchers at the University of Illinois at Chicago.
The costs associated with neurological diseases amount to 1000 billion euros per year in Europe alone.
Barr Pharmaceuticals, Inc. today announced that its subsidiary, Barr Laboratories, Inc., received final approval from the U.S. Food & Drug Administration (FDA) to manufacture and market a generic version of Ortho McNeil Janssen's Razadyne (galantamine hydrobromide), 4 mg, 8 mg and 12 mg tablets. Barr intends to launch its generic Razadyne tablets product immediately.
Human Genome Sciences, Inc. and Aegera Therapeutics, Inc. today announced that HGS has initiated dosing in a Phase 1 clinical trial to evaluate the safety and tolerability of its lead IAP inhibitor, HGS1029, as monotherapy in patients with advanced lymphoid tumors.
› Verified 6 days ago
News Archive
In a study to be presented on Feb. 5 in an oral pleanary session at 8 a.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting™, in San Diego, researchers will report that induced or augmented labor are not associated with increased odds of Autism spectrum disorder.
An RNA-binding protein that is overproduced in ovarian cancer may present a new target for diagnosis or treatment of ovarian and other cancers, according to researchers at the University of Illinois at Chicago.
The costs associated with neurological diseases amount to 1000 billion euros per year in Europe alone.
Barr Pharmaceuticals, Inc. today announced that its subsidiary, Barr Laboratories, Inc., received final approval from the U.S. Food & Drug Administration (FDA) to manufacture and market a generic version of Ortho McNeil Janssen's Razadyne (galantamine hydrobromide), 4 mg, 8 mg and 12 mg tablets. Barr intends to launch its generic Razadyne tablets product immediately.
Human Genome Sciences, Inc. and Aegera Therapeutics, Inc. today announced that HGS has initiated dosing in a Phase 1 clinical trial to evaluate the safety and tolerability of its lead IAP inhibitor, HGS1029, as monotherapy in patients with advanced lymphoid tumors.
› Verified 6 days ago
Preferred Homecare Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2153 E Gordon Drive, Kingman, Arizona 86409 Phone: (928) 692-9401 | |
Cvs Pharmacy #08977 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3501 Stockton Hill Rd, Kingman, Arizona 86409 Phone: (928) 757-1999 | |
Uptown Pharmacy Of Kingman Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2820 E Andy Devine Ave, Kingman, Arizona 86401 Phone: (928) 753-2738 | |
Walmart Pharmacy 10-2051 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3396 Stockton Hill Rd, Kingman, Arizona 86409 Phone: (928) 692-0444 | |
Safeway Pharmacy #1887 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3970 Stockton Hill Rd, Kingman, Arizona 86409 Phone: (928) 681-4903 |